HABA Laboratories,Inc. (TYO:4925)
Japan · Delayed Price · Currency is JPY 1,760.00
+8.00 (0.46%)
Jul 31, 2026, 2:10 PM JST
HABA Laboratories,Inc. Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 850 | 635 | -1,843 | -548 | -266 |
Depreciation & Amortization | 186 | 158 | 519 | 559 | 708 |
Loss (Gain) From Sale of Assets | -130 | - | 1,651 | -5 | 52 |
Loss (Gain) From Sale of Investments | - | -7 | - | - | - |
Other Operating Activities | -84 | 4 | -223 | 68 | 264 |
Change in Accounts Receivable | -56 | 72 | -284 | 142 | 93 |
Change in Inventory | 350 | 791 | -344 | -216 | 883 |
Change in Accounts Payable | 138 | -71 | -167 | 114 | 29 |
Change in Other Net Operating Assets | -17 | 39 | 104 | -59 | -49 |
Operating Cash Flow | 1,237 | 1,621 | -587 | 55 | 1,714 |
Operating Cash Flow Growth | -23.69% | - | - | -96.79% | 220.97% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -77 | -138 | -154 | -191 | -124 |
Sale of Property, Plant & Equipment | 654 | - | 18 | 30 | 8 |
Sale (Purchase) of Intangibles | -32 | -73 | -278 | -97 | -63 |
Investment in Securities | -100 | 11 | - | - | - |
Other Investing Activities | 39 | 53 | -27 | 44 | -37 |
Investing Cash Flow | 484 | -147 | -441 | -214 | -216 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Short-Term Debt Issued | - | - | 400 | - | - |
Long-Term Debt Issued | 400 | 400 | 800 | 400 | 400 |
Total Debt Issued | 400 | 400 | 1,200 | 400 | 400 |
Short-Term Debt Repaid | -400 | -100 | - | -100 | -800 |
Long-Term Debt Repaid | -629 | -838 | -877 | -825 | -961 |
Total Debt Repaid | -1,029 | -938 | -877 | -925 | -1,761 |
Net Debt Issued (Repaid) | -629 | -538 | 323 | -525 | -1,361 |
Common Dividends Paid | -151 | -151 | -151 | -151 | -151 |
Other Financing Activities | - | - | -1 | - | - |
Financing Cash Flow | -780 | -689 | 171 | -676 | -1,512 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Foreign Exchange Rate Adjustments | - | - | - | 1 | 2 |
Miscellaneous Cash Flow Adjustments | -1 | -1 | -1 | 1 | - |
Net Cash Flow | 940 | 784 | -858 | -833 | -12 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 1,160 | 1,483 | -741 | -136 | 1,590 |
Free Cash Flow Growth | -21.78% | - | - | - | - |
Free Cash Flow Margin | 9.55% | 12.30% | -6.01% | -1.13% | 12.32% |
Free Cash Flow Per Share | 306.76 | 392.17 | -195.95 | -35.96 | 420.46 |
Levered Free Cash Flow | 1,006 | 1,240 | -964.5 | 131.63 | 1,548 |
Unlevered Free Cash Flow | 1,016 | 1,250 | -958.88 | 135.38 | 1,552 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 17 | 17 | 9 | 5 | 6 |
Cash Income Tax Paid | 93 | 23 | 228 | -6 | -154 |
Change in Working Capital | 415 | 831 | -691 | -19 | 956 |